1. COMMENTARY: The Right Diagnosis, but the Wrong Prescription
The Global Fund needs a new Office of the Inspector General, not just a new Inspector General, writes Josef Decosas, responding to a commentary by Bernard Rivers in GFO 203. “We don’t need to be afraid that the fraud investigation unit of the Global Fund will disappear,” Mr Decosas says. “What is likely to disappear is an opportunity for a transparent evaluation and audit function to monitor the practices of grant funding and grant implementation.”
Norbert Hauser has been appointed as Interim Inspector General. Mr Hauser will serve until the search is completed for a new Inspector General to replace John Parsons.
The Global Fund is still experiencing large year-over-year increases in its results numbers. At the end of 2012, the number of people receiving antiretrovirals was up 27% over 2011. Over that same period, the number of insecticide-treated nets distributed for malaria increased 35%, and the number of HIV behavioural change communications rose by 88%.
The Global Fund has slightly lowered its forecast of uncommitted assets as of December 2014 to $1,326 million from the $1,428 million forecasted in September 2012.
At its annual meeting, the Civil Society Principal Recipients Network raised a number of concerns related to grant implementation and formulated a set of recommendations for the Global Fund. This article provides details.
The US President’s Emergency Plan for AIDS Relief has promised to step up its collaboration with the Global Fund in countries where both organisations are investing.
A new study blames low success rates of multi-country malaria grant applications on inadequate guidance from the Global Fund and warns that this could affect malaria control efforts in sub-Saharan Africa.
A report released by the grassroots advocacy organization ONE contains information on donor commitments to the Global Fund.